Identification of addicsin/GTRAP3-18 as a chronic morphine-augmented gene in amygdala

NeuroReport

Volumn 13, Issue 16, 2002, Pages 2079-2084

  Ikemoto, Mitsushi J ^a   Inoue, Koutarou ^b   Akiduki, Saori ^a,c   Osugi, Takeshi ^d   Imamura, Toru ^a   Ishida, Norio ^a   Ohtomi, Michiko ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c NEW ENERGY AND INDUSTRIAL TECHNOLOGY DEVELOPMENT ORGANIZATION   (Japan)

^d NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

Author keywords

Addicsin; Addiction; Basomedial amygdala nucleus; Chronic morphine administration; Gene expression; GTRAP3 18; Mature brain; Mouse; mRNA; Soluble protein

Indexed keywords

ADDICSIN; COMPLEMENTARY DNA; GLUTAMATE TRANSPORTER; GLUTAMATE TRANSPORTER ASSOCIATED PROTEIN 3 18; MESSENGER RNA; MORPHINE; PROTEIN; PROTEIN KINASE C; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; CHROMOSOMAL LOCALIZATION; DRUG DEPENDENCE; ENZYME PHOSPHORYLATION; GENE EXPRESSION; MOLECULAR CLONING; MORPHINE ADDICTION; MOUSE; NARCOTIC DEPENDENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINO ACID SEQUENCE; AMYGDALA; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM; DNA, COMPLEMENTARY; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; MORPHINE; NARCOTICS; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, OPIOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 0037113345     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200211150-00018     Document Type: Article

References (25)

1. Di Chiara G and North RA. Trends Pharmacol Sci 13, 185-193 (1992).
2. Sharma SK, Klee WA and Nirenberg M. Proc Natl Acad Sci USA 72, 3092-3096 (1975).
3. Guitart X, Thompson MA, Mirante CK et al. J Neurochem 58, 1168-1171 (1992).
4. Ikemoto M, Osugi T, Wang XB et al. Neuroreport 6, 262-264 (1995).
5. Nestler EJ. Nature Rev Neurosci 2, 119-128 (2001).
6. Maldonado R, Blendy JA, Tzavara E et al. Science 273, 657-659 (1996).
7. Blendy JA and Maldonado R. J Mol Med 76, 104-110 (1998).
8. Sklair-Tavron L, Shi WX, Lane SB et al. Proc Natl Acad Sci USA 93, 11202-11207 (1996).
9. Ikemoto M, Takita M, Imamura T et al. Nature Med 6, 910-915 (2000).
10. Lin CI, Orlov I, Ruggiero AM et al. Nature 410, 84-88 (2001).
11. Kaneto H, Koida M, Nakanishi HK et al. Jpn J Pharmacol 23, 701-707 (1973).
12. Altschul SF, Gish W, Miller W et al. J Mol Biol 215, 403-410 (1990).
13. Pearson WR and Lipman DJ. Proc Natl Acad Sci USA 85, 2444-2448 (1988).
14. Chomczynski P and Sacchi N. Anal Biochem 162, 156-159 (1987).
15. Jones RW and Jones MJ. Biotechniques 12, 684-688 (1992).
16. Towbin H, Staehelin T and Gordon J. Biotechnology 24, 145-149 (1992).
17. Kyte J and Doolittle RF. J Mol Biol 157, 105-132 (1982).
18. Kozak M. Nucleic Acids Res 12, 857-872 (1984).
19. McLemore GL, Kest B and Inturrisi CE. Brain Res 778, 120-126 (1997).
20. Vandergriff J and Rasmussen K. Neuropharmacology 38, 217-222 (1999).
21. Vekovischeva OY, Zamanillo D, Echenko O et al. J Neurosci 21, 4451-4459 (2001).
22. Trujillo KA and Akil H. Science 251, 85-87 (1991).
23. Gonzalez P, Cabello P, Germany A et al. Eur J Pharmacol 332, 257-262 (1997).
24. Nakagawa T, Ozawa T, Shige K et al. Eur J Pharmacol 419, 39-45 (2001).
25. Rothstein JD, Martin L, Levey AI et al. Neuron 13, 713-725 (1994).